CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced study results that further demonstrate the potential for use of ...

Universal gene‑edited CAR‑T therapies turn donor T cells into off‑the‑shelf cancer treatments, cutting delays and costs while ...

Let us help you with your inquiries, brochures and pricing requirements Request A Quote Download PDF Copy Request A Quote Download PDF Copy Request A Quote Download ...

The CEO of ModeX Therapeutics discusses MDX2003, a groundbreaking tetraspecific therapy that promises enhanced efficacy and ...

How do immune cells strike a balance, unleashing rapid attacks against pathogens or cancer, while avoiding damage to healthy ...

Recombinant cytokines and growth factors are essential components for cell culture. Since they are so widely used, it is worth taking a closer look at them and understand their characteristics. When ...

Researchers have developed a new method of locally delivering cytokines alongside T cells that could lead to improved CAR-T cell therapies. CAR-T cell therapies utilize engineered T cells that have a ...

Stem cells are a class of multipotential cells that can self-replicate, self-renew, and differentiate into multiple cell lines. Stem cells provide a more realistic method of identifying and confirming ...

CULVER CITY, Calif.--(BUSINESS WIRE)--ImmunityBio, Inc. (NASDAQ: IBRX), a clinical-stage immunotherapy company, today announced new data showing that the company’s Memory Cytokine-Enriched Natural ...

T cells, together with B cells, are the workhorses of the adaptive immune response. And although some cells that are associated with the innate immune response can take on adaptive properties, it has ...